Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

BACKGROUND: Methylxanthines and leukotriene receptor antagonists (LTRA) are not a first-line medical treatment for chronic obstructive pulmonary disease (COPD) but are frequently prescribed despite limited evidence. We aimed to elucidate the real prescribing status and clinical impacts of these agen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Chron Obstruct Pulmon Dis
Main Authors: Lee, Jung-Kyu, Rhee, Chin Kook, Kim, Kyungjoo, Ra, Seung Won, Lee, Jae Ha, Jung, Ki-Suck, Yoo, Kwang Ha, Kim, Yoo-Il, Kim, Deog Kyeom
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://ncbi.nlm.nih.gov/pubmed/31819397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S216326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados